|
Login
Directory:
Add Company
| Your company can benefit
from enhanced listings. Questions? Read our FAQ
first. |
Personalized notification service and newsletter info
| Subscribe (free) to get notified
of new additions. |
Learn more About us and about our Services
Contact us
|
ReNeuron Ltd. 
|
|
ReNeuron Ltd - Corporate profile: Developing immortalised human cell lines for clinical brain repair. The Company is now engaged in developing its first clonal human cell lines, following infection of brain stem cells with the immortalizing oncogene. The intention is to develop cell lines for the treatment of Stroke, Parkinson's disease, Huntington's disease and Cerebral Palsy. The first phase I/II clinical trials are set to commence in Q4 2000.
Activity:
Product / Technology type(s) covered:
- Bio
- Technology
Therapeutic targets:
- Genetics
|
|
Company Contact
|
ReNeuron Ltd.
United Kingdom
Phone:
FAX:
Website: www.reneuron.com
|
|
Markets Covered
a. HeadQuarter:
b. Continent(s) active:
c. Countries active:
Corporate data:
Number of Employees:
Turnover:
Year founded:
|
Suggestion box |
Disclaimer | Privacy
Policy | Rules & Regulations
Copyright© Cofidei, Inc. Page last modified: .
|